tetraethylammonium has been researched along with ergoline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lacey, MG; Mercuri, NB; North, RA | 1 |
| O'Malley, KL; Tang, L; Todd, RD | 1 |
2 other study(ies) available for tetraethylammonium and ergoline
| Article | Year |
|---|---|
Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta.
Topics: Action Potentials; Animals; Dopamine; Ergolines; In Vitro Techniques; Ion Channels; Male; Neurons; Potassium; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra; Tetraethylammonium; Tetraethylammonium Compounds; Tetrodotoxin; Time Factors | 1987 |
Dopamine D2 and D3 receptors inhibit dopamine release.
Topics: 4-Aminopyridine; Animals; Cell Line; Dopamine; Ergolines; Humans; Membrane Potentials; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Recombinant Proteins; Salicylamides; Tetraethylammonium; Tetraethylammonium Compounds | 1994 |